Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ventyx Biosciences Inc (VTYX)

Ventyx Biosciences Inc (VTYX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Ventyx Biosciences Inc 12790 EL CAMINO REAL SUITE 200 SAN DIEGO CA 92130 USA

www.ventyxbio.com Employees: 80 P: 760-593-4832

Description:

Ventyx Biosciences Inc. is a clinical-stage biopharmaceutical company. It focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders. The company's clinical stage pipeline includes VTX958, VTX002 and VTX2735. Ventyx Biosciences Inc. is headquartered in Encinitas, California.

Key Statistics

Overview:

Market Capitalization, $K 121,623
Enterprise Value, $K 70,043
Shares Outstanding, K 70,711
Annual Sales, $ 0 K
Annual Net Income, $ -192,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -35,250 K
EBIT, $ -166,380 K
EBITDA, $ -165,440 K
60-Month Beta 0.37
% of Insider Shareholders 18.18%
% of Institutional Shareholders 97.88%
Float, K 57,856
% Float 81.82%
Short Volume Ratio 0.60

Growth:

1-Year Return -25.75%
3-Year Return -92.29%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.50 on 11/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.36
EPS Growth vs. Prev Qtr -11.11%
EPS Growth vs. Prev Year 45.65%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VTYX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.94%
Return-on-Assets % -50.01%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.45
Book Value/Share 3.94
Interest Coverage -4.99
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar